News & Notes
- OTT Start-up: NeurOp Initiates Phase 1 Clinical Trial of NMDA Receptor Inhibitor ... View More
- OTT Start-up: Cambium Receives $5M Series A Investment (View More) and Receives FDA Approval for Phase I/II Trial (View More)
- OTT Start-up: Incysus Receives FDA Approval for Phase I Trial ... View More
- OTT Start-up: Meissa Vaccines Announces Seed Round Investment from FundRx ... View More
Personalizing Prostate Cancer Treatment with Math
Mohammad K. Khan, MD, PhD
Individuals experience distinct motion movements during radiation, current methods utilize uniform radiation treatment margins around the prostate for all patients. Radiation aimed using these uniform margins may not adequately target the moving tumor, and might instead expose surrounding organs. Utilizing mathmatical models the radiation treatments can be personalized to account for these movements.